New TRITON/L200 to be debuted soon

Press Releases »

          For 40 years, Mitsubishi Motors has been building tough pickups. More than 4.7 million TRITONs/L200s have been made and are trusted by owners all over the world to help drive their ambition, with smart capabilities combined with car-like comfort. It's almost time to reveal the next chapter in the TRITON story. Designed to be "Engineered Beyond Tough", the new model has enhanced performance, functionality, durability, safety and refinement. It has been proven by tough, real-world durability testing and developed using feedback from owners across the world. Discover the tough new TRITON on November 9th.
New TRITON/L200 to be debuted soon
 
          About Mitsubishi Motors Thailand (MMTh) 
          Mitsubishi Motors (Thailand) Co., Ltd., the largest plant in the MMC group and an export hub to more than 120 countries, is one of Thailand's leading automotive manufacturers committed to produce and sell a range of vehicles that are eco-friendly, high in quality, performance, safety, comfort, technology and customer satisfaction. In 2018 MMTh celebrated a total production of five million units, and officially opened Education Academy in Pathum Thani. MMTh's current range of vehicles includes the Mitsubishi Triton, Mitsubishi Pajero Sport, Mitsubishi Attrage, and Mitsubishi Mirage. To ensure the highest quality, MMTh uses its proving ground in Sriracha, Chonburi to assess products from design and prototype stages to pre-production and commercialization. This ensures customers take delivery of vehicles that are second-to-none in all aspects of quality. 
          Please contact Mitsubishi dealers nationwide for more information and test driving, or contact Mitsubishi Call Center Tel. 02-079-9500 every day at 8:30 – 17:00 hrs.
          Stay updated with Mitsubishi Motors Thailand;
          Website : www.mitsubishi-motors.co.th
          Facebook : www.facebook.com/MitsubishiMotorsTH
          Instagram : @MitsubishiMotorsTh
          Youtube Channel : Mitsubishi Motors Thailand
          Line Official Account/ ID : Mitsubishi Motors Th / @MitsubishiMotorsTh
 

ข่าวthe TRITON+motorวันนี้

Bangchak Continues E85 Alternative Fuel at Affordable Price Expands Self-Service Stations to Reduce Costs for Motorists

Amid global oil price volatility driven by tensions in the Middle East, Bangchak Corporation Public Company Limited continues to offer E85 gasohol, an alternative fuel containing a high proportion of ethanol. The fuel helps reduce reliance on fossil fuels while lowering energy expenses for motorists whose vehicles support E85. Bangchak currently offers E85 at 81 service stations nationwide. The current price is THB 25.79 per liter (Bangkok price, excluding local taxes), significantly lower than

"IMC สื่อสากล" จับรางวัลหาผู้โชคดีจากงาน ... MOTOR EXPO คืนกำไรผู้ชมอลังการ จับรางวัล รถยนต์ 3 คัน จักรยานยนต์ 1 คัน — "IMC สื่อสากล" จับรางวัลหาผู้โชคดีจากงาน "มหกรรมยานยนต์ ครั้งที่ 42" ลุ้นรถยนต์ ...

Lalamove Celebrates the Festive Season with "Santa LALA's Ride" Big Giveaway Campaign for Users and Driver Partners

Lalamove, the on-demand delivery and ride-hailing platform, is launching a special year-end campaign, "Santa LALA's Ride," to celebrate the festive season. The campaign invites both...

Mitsubishi Motors Corporation (MMC) today... Mitsubishi Motors Goes “ABSOLUTELY Beyond Tough” with Iconic Special Show Model TRITON ABSOLUTE — Mitsubishi Motors Corporation (MMC) today unveiled the T...

Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel

A sub-analysis of the TRITON-TIMI 38 clinical trial showed that treatment with prasugrel compared with clopidogrel significantly reduced the risk of new or...

Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel

Sub-group analysis of landmark trial showed prasugrel substantially reduced risk of heart attack and stent thrombosis compared with clopidogrel among ACSpatients with...